• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妇科癌症及其细胞系。

Gynaecological cancers and their cell lines.

机构信息

Department of pathology, General Hospital Graz II, Graz, Austria.

Institute of Biomedical Sciences, Faculty of Medicine, University of Maribor, Maribor, Slovenia.

出版信息

J Cell Mol Med. 2021 Apr;25(8):3680-3698. doi: 10.1111/jcmm.16397. Epub 2021 Mar 2.

DOI:10.1111/jcmm.16397
PMID:33650759
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8051715/
Abstract

Cell lines are widely used for various research purposes including cancer and drug research. Recently, there have been studies that pointed to discrepancies in the literature and usage of cell lines. That is why we have prepared a comprehensive overview of the most common gynaecological cancer cell lines, their literature, a list of currently available cell lines, and new findings compared with the original studies. A literature review was conducted via MEDLINE, PubMed and ScienceDirect for reviews in the last 5 years to identify research and other studies related to gynaecological cancer cell lines. We present an overview of the current literature with reference to the original studies and pointed to certain inconsistencies in the literature. The adherence to culturing rulesets and the international guidelines helps in minimizing replication failure between institutions. Evidence from the latest research suggests that despite certain drawbacks, variations of cancer cell lines can also be useful in regard to a more diverse genomic landscape.

摘要

细胞系被广泛应用于各种研究目的,包括癌症和药物研究。最近,有研究指出细胞系在文献和使用方面存在差异。这就是为什么我们准备了一份最常见妇科癌症细胞系的综合概述,包括它们的文献、目前可用的细胞系列表,以及与原始研究相比的新发现。通过 MEDLINE、PubMed 和 ScienceDirect 进行了文献回顾,以查找过去 5 年内与妇科癌症细胞系相关的研究和其他研究。我们参考原始研究,概述了当前的文献,并指出文献中存在某些不一致之处。遵守培养规则和国际准则有助于最大限度地减少机构间复制失败。最新研究的证据表明,尽管存在某些缺点,但癌细胞系的变异在更广泛的基因组景观方面也可能是有用的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e4/8051715/898614194115/JCMM-25-3680-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e4/8051715/f8f1177cb72e/JCMM-25-3680-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e4/8051715/662efd9af24d/JCMM-25-3680-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e4/8051715/15f1342ed783/JCMM-25-3680-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e4/8051715/083588c004db/JCMM-25-3680-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e4/8051715/a106de851013/JCMM-25-3680-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e4/8051715/898614194115/JCMM-25-3680-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e4/8051715/f8f1177cb72e/JCMM-25-3680-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e4/8051715/662efd9af24d/JCMM-25-3680-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e4/8051715/15f1342ed783/JCMM-25-3680-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e4/8051715/083588c004db/JCMM-25-3680-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e4/8051715/a106de851013/JCMM-25-3680-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3e4/8051715/898614194115/JCMM-25-3680-g002.jpg

相似文献

1
Gynaecological cancers and their cell lines.妇科癌症及其细胞系。
J Cell Mol Med. 2021 Apr;25(8):3680-3698. doi: 10.1111/jcmm.16397. Epub 2021 Mar 2.
2
Endometrial cancer and its cell lines.子宫内膜癌及其细胞系。
Mol Biol Rep. 2020 Feb;47(2):1399-1411. doi: 10.1007/s11033-019-05226-3. Epub 2019 Dec 17.
3
Diagnostic immunohistochemistry in gynaecological neoplasia: a brief survey of the most common scenarios.妇科肿瘤中的诊断性免疫组织化学:最常见情况的简要概述。
J Clin Pathol. 2018 Feb;71(2):98-109. doi: 10.1136/jclinpath-2017-204787. Epub 2017 Nov 28.
4
Sentinel lymph node sampling in gynaecological cancers: techniques and clinical applications.妇科癌症前哨淋巴结取样:技术与临床应用
Eur J Surg Oncol. 2009 Jul;35(7):675-85. doi: 10.1016/j.ejso.2008.09.004. Epub 2008 Nov 2.
5
Assessment of the invasive potential of human gynecological tumor cell lines with the in vitro Boyden chamber assay: influences of the ability of cells to migrate through the filter membrane.采用体外Boyden小室试验评估人妇科肿瘤细胞系的侵袭潜能:细胞穿过滤膜迁移能力的影响
Clin Exp Metastasis. 1997 Jan;15(1):53-62. doi: 10.1023/a:1018436407280.
6
Second primitive malignant tumour in patients with gynaecological cancer.妇科癌症患者的第二种原发性恶性肿瘤。
Eur J Gynaecol Oncol. 1997;18(6):488-91.
7
The changing landscape of gynaecological cancer diagnosis: implications for histopathological practice in the 21st century.妇科癌症诊断的变化态势:对21世纪组织病理学实践的影响
Histopathology. 2017 Jan;70(1):56-69. doi: 10.1111/his.13080.
8
[Occurrence of second and third malignant tumors in patients with gynaecological cancer].[妇科癌症患者中第二原发性和第三原发性恶性肿瘤的发生情况]
Akush Ginekol (Sofiia). 2005;44(3):22-4.
9
[Current classification of malignant tumours in gynecological oncology--part II].[妇科肿瘤学中恶性肿瘤的当前分类——第二部分]
Ceska Gynekol. 2011 Oct;76(5):360-6.
10
The growth response to tumour necrosis factor alpha of human gynaecological cancer cell lines.人妇科癌细胞系对肿瘤坏死因子α的生长反应。
Cytokine. 1998 Jun;10(6):432-40. doi: 10.1006/cyto.1997.9997.

引用本文的文献

1
Functional Profiling of p53 and RB Cell Cycle Regulatory Proficiency Suggests Mechanism-Driven Molecular Stratification in Endometrial Carcinoma.p53和RB细胞周期调控能力的功能分析提示子宫内膜癌中存在机制驱动的分子分层。
Cancer Res Commun. 2025 Apr 1;5(4):719-742. doi: 10.1158/2767-9764.CRC-24-0028.
2
Data-Driven Modelling of Substituted Pyrimidine and Uracil-Based Derivatives Validated with Newly Synthesized and Antiproliferative Evaluated Compounds.基于数据驱动的取代嘧啶和尿嘧啶衍生物建模,经新合成化合物和抗增殖活性评估验证。
Int J Mol Sci. 2024 Aug 29;25(17):9390. doi: 10.3390/ijms25179390.
3
Identification and subsequent validation of transcriptomic signature associated with metabolic status in endometrial cancer.

本文引用的文献

1
The 2019 World Health Organization classification of tumours of the breast.《2019年世界卫生组织乳腺肿瘤分类》
Histopathology. 2020 Aug;77(2):181-185. doi: 10.1111/his.14091. Epub 2020 Jul 29.
2
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
3
Endometrial cancer and its cell lines.子宫内膜癌及其细胞系。
鉴定和随后验证与子宫内膜癌代谢状态相关的转录组特征。
Sci Rep. 2023 Aug 23;13(1):13763. doi: 10.1038/s41598-023-40994-w.
4
Tumor Organoid and Spheroid Models for Cervical Cancer.宫颈癌的肿瘤类器官和球体模型
Cancers (Basel). 2023 Apr 27;15(9):2518. doi: 10.3390/cancers15092518.
5
Knockdown of the stem cell marker Musashi-1 inhibits endometrial cancer growth and sensitizes cells to radiation.敲低干细胞标志物 Musashi-1 可抑制子宫内膜癌生长并增强细胞对放疗的敏感性。
Stem Cell Res Ther. 2022 May 26;13(1):212. doi: 10.1186/s13287-022-02891-3.
6
MFUM-BrTNBC-1, a Newly Established Patient-Derived Triple-Negative Breast Cancer Cell Line: Molecular Characterisation, Genetic Stability, and Comprehensive Comparison with Commercial Breast Cancer Cell Lines.MFUM-BrTNBC-1,一种新建立的患者来源的三阴性乳腺癌细胞系:分子特征、遗传稳定性以及与商业乳腺癌细胞系的全面比较。
Cells. 2021 Dec 30;11(1):117. doi: 10.3390/cells11010117.
Mol Biol Rep. 2020 Feb;47(2):1399-1411. doi: 10.1007/s11033-019-05226-3. Epub 2019 Dec 17.
4
Interpretation of somatic POLE mutations in endometrial carcinoma.子宫内膜癌中体 POLE 突变的解读。
J Pathol. 2020 Mar;250(3):323-335. doi: 10.1002/path.5372. Epub 2020 Jan 29.
5
Isolation and characterization of the first Slovenian human triple-negative breast cancer cell line.首例斯洛文尼亚人三阴性乳腺癌细胞系的分离与鉴定
Breast J. 2020 Feb;26(2):328-330. doi: 10.1111/tbj.13695. Epub 2019 Nov 20.
6
Cervical Cancer Cells Express Markers Associated with Immunosurveillance.宫颈癌细胞表达与免疫监视相关的标志物。
J Immunol Res. 2019 May 6;2019:1242979. doi: 10.1155/2019/1242979. eCollection 2019.
7
Next-generation characterization of the Cancer Cell Line Encyclopedia.下一代癌症细胞系百科全书的特征描述。
Nature. 2019 May;569(7757):503-508. doi: 10.1038/s41586-019-1186-3. Epub 2019 May 8.
8
An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines.癌症细胞系遗传多样性和祖源分析的交互式资源
Cancer Res. 2019 Apr 1;79(7):1263-1273. doi: 10.1158/0008-5472.CAN-18-2747. Epub 2019 Mar 20.
9
Establishment, molecular and biological characterization of HCB-514: a novel human cervical cancer cell line.建立、分子和生物学鉴定 HCB-514:一种新型人宫颈癌细胞系。
Sci Rep. 2019 Feb 13;9(1):1913. doi: 10.1038/s41598-018-38315-7.
10
Impact of screening on cervical cancer incidence in England: a time trend analysis.英国宫颈癌发病率筛查效果的时间趋势分析。
BMJ Open. 2019 Jan 24;9(1):e026292. doi: 10.1136/bmjopen-2018-026292.